Freestone Capital Holdings’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,000	Closed	-$8.8K	–	776
2020 Q4	$8.8K	Hold	5,000	–	–	﹤0.01%	876
2020 Q3	$4.68K	Buy	+5,000	New	+$4.68K	﹤0.01%	891